LICENSE AGREEMENTS AND DEFERRED REVENUE (Details Textual) (USD $)	6 Months Ended		1 Months Ended	3 Months Ended		6 Months Ended			6 Months Ended		3 Months Ended		6 Months Ended
	May 31, 2014	May 09, 2014 Rutgers License Agreement [Member]	Sep. 30, 2010 Rutgers License Agreement [Member] Xenogenics [Member]	May 31, 2014 Corning Incorporated [Member]	May 31, 2013 Corning Incorporated [Member]	May 31, 2014 Corning Incorporated [Member]	May 31, 2013 Corning Incorporated [Member]	Nov. 30, 2013 Corning Incorporated [Member]	May 31, 2014 Corning Incorporated [Member] Execution Of Licence Agreement [Member]	May 31, 2014 Corning Incorporated [Member] Completion Of Licence Agreement [Member]	May 31, 2014 Pfizer Incorporated [Member]	May 31, 2013 Pfizer Incorporated [Member]	May 31, 2014 Pfizer Incorporated [Member]	May 31, 2013 Pfizer Incorporated [Member]	Nov. 30, 2013 Pfizer Incorporated [Member]
Deferred Revenue Arrangement [Line Items]
License and Maintenance Revenue									$ 375,000	$ 375,000
Deferred Revenue, Revenue Recognized				11,030	11,030	22,059	22,059				1,300	1,300	2,600	2,600
Deferred Revenue				455,883		455,883		477,942			18,200		18,200		20,800
Deferred Revenue, Amortization Period						2024-10							2018-01
License And Purchase Agreement Description	The Company has an exclusive license and purchase agreement (the Agreement) with Corning Incorporated (Corning) of Corning, New York.
License Costs			50,000
License Maintenance Fee For Third Anniversary			25,000
License Maintenance Fee For Fourth Anniversary			50,000
License Agreement, Unpaid Costs			136,000
Unpaid License Fees		25,000
Unpaid Patent Costs		75,665
License Agreement, Accrued Interest		$ 8,375